pp – -Translation – Keybot Dictionary

Spacer TTN Translation Network TTN TTN Login Deutsch Français Spacer Help
Source Languages Target Languages
Keybot 15 Results  ar2006.emcdda.europa.eu
  Bibliography  
Van den Brink, W. (2005), ‘Epidemiology of cocaine and crack: implications for drug policy and treatment’, Sucht 51(4), pp. 196–8.
Van den Brink, W. (2005), «Epidemiology of cocaine and crack: implications for drug policy and treatment», Sucht 51(4), pp. 196–8.
Van den Brink, W. (2005), „Epidemiology of cocaine and crack: implications for drug policy and treatment“, Sucht 51(4), S. 196-198.
Van den Brink, W. (2005), «Epidemiology of cocaine and crack: implications for drug policy and treatment», Sucht 51(4), pp. 196-198.
Van den Brink, W. (2005), ‘Epidemiology of cocaine and crack: implications for drug policy and treatment’, Sucht 51(4), pagg. 196–8.
Van den Brink, W. (2005), ‘Epidemiology of cocaine and crack: implications for drug policy and treatment’, Sucht 51(4), σσ. 196–8.
Van den Brink, W. (2005), ‘Epidemiology of cocaine and crack: implications for drug policy and treatment’, Sucht 51(4), blz. 196-198.
Van den Brink, W. (2005), „Epidemiology of cocaine and crack: implications for drug policy and treatment“, Sucht 51(4), str. 196–198.
Van den Brink, W. (2005): "Epidemiology of cocaine and crack: implications for drug policy and treatment", Sucht 51(4), s. 196–198.
Van den Brink, W. (2005), ”Epidemiology of cocaine and crack: implications for drug policy and treatment”, Sucht vol. 51 (4), s. 196–198.
Van den Brink, W. (2005), „Epidemiology of cocaine and crack: implications for drug policy and treatment”, Sucht 51(4), 196–8. o.
Van den Brink, W. (2005), ‘Epidemiology of cocaine and crack: implications for drug policy and treatment’, Sucht 51(4), s. 196-8.
Van den Brink, W. (2005), ‘Epidemiology of cocaine and crack: implications for drug policy and treatment’, Sucht 51(4), s 196 –8.
Van den Brink, W. (2005), ‘Epidemiology of cocaine and crack: implications for drug policy and treatment’, Sucht 51(4), str. 196–8.
Van den Brink, W. (2005), ‘Epidemiology of cocaine and crack: implications for drug policy and treatment’, Sucht 51(4), s. 196–8.
Van den Brink, W. (2005), ‘Epidemiology of cocaine and crack: implications for drug policy and treatment’, Sucht 51(4), ss. 196–8.
  Bibliography  
Bossong, M.G., Van Dijk, J.P. and Niesink, R.J.M. (2005), ‘Methylone and mCPP, two new drugs of abuse?’, Addiction biology 10(4), pp. 321–3.
Bossong, M.G., Van Dijk, J.P. et Niesink, R.J.M. (2005), «Methylone and mCPP, two new drugs of abuse?», Addiction biology 10(4), pp. 321–3.
Bossong, M. G., Van Dijk, J. P. und Niesink, R. J. M. (2005), „Methylone and mCPP, two new drugs of abuse?“, Addiction biology 10(4), S. 321-323.
Bossong, M.G., Van Dijk, J.P. y Niesink, R.J.M. (2005), «Methylone and mCPP, two new drugs of abuse?», Addiction biology 10(4), pp. 321-3.
Bossong, M.G., Van Dijk, J.P. and Niesink, R.J.M. (2005), ‘Methylone and mCPP, two new drugs of abuse?’, Addiction biology 10(4), pagg. 321–3.
Bossong, M.G., Van Dijk, J.P. και Niesink, R.J.M. (2005), ‘Methylone and mCPP, two new drugs of abuse?’, Addiction biology 10(4), σσ. 321–3.
Bossong, M.G., Van Dijk, J.P. en Niesink, R.J.M. (2005), ‘Methylone and mCPP, two new drugs of abuse?’, Addiction biology 10(4), blz. 321-323.
Bossong, M.G., Van Dijk, J.P. a Niesink, R.J.M. (2005), „Methylone and mCPP, two new drugs of abuse?’, Addiction biology 10(4), str. 321–323.
Bossong, M.G., Van Dijk, J.P. og Niesink, R.J.M. (2005): "Methylone and mCPP, two new drugs of abuse?", Addiction biology 10(4), s. 321–323.
Bossong, M.G., Van Dijk, J.P. ja Niesink, R.J.M. (2005), ”Methylone and mCPP, two new drugs of abuse?”, Addiction biology vol. 10 (4), s. 321–323.
Bossong, M.G., Van Dijk, J.P. és Niesink, R.J.M. (2005), „Methylone and mCPP, two new drugs of abuse?”, Addiction biology 10(4), 321–3. o.
Bossong, M.G., Van Dijk, J.P. og Niesink, R.J.M. (2005), ‘Methylone and mCPP, two new drugs of abuse?’, Addiction biology 10(4), s. 321–3.
Bossong, M.G., Van Dijk, J.P. a Niesink, R.J.M. (2005), ‘Methylone and mCPP, two new drugs of abuse?’, Addiction biology 10(4), s. 321–3.
Bossong, M.G., Van Dijk, J.P. in Niesink, R.J.M. (2005), ‘Methylone and mCPP, two new drugs of abuse?’, Addiction biology 10(4), str. 321–3.
Bossong, M.G., Van Dijk, J.P. and Niesink, R.J.M. (2005), ‘Methylone and mCPP, two new drugs of abuse?’, Addiction biology 10(4), s. 321–3.
Bossong, M.G., Van Dijk, J.P. ve Niesink, R.J.M. (2005), ‘Methylone and mCPP, two new drugs of abuse?’, Addiction biology 10(4), ss. 321–3.
  Bibliography  
Roe, E. and Becker, J (2005), ‘Drug prevention with vulnerable young people: a review’, Drugs: education, prevention and policy, 12(2), pp. 85–99.
Roe, E. et Becker, J (2005), «Drug prevention with vulnerable young people: a review», Drugs: education, prevention and policy, 12(2), pp. 85–99.
Roe, E. und Becker, J. (2005), „Drug prevention with vulnerable young people: a review“, Drugs: education, prevention and policy, 12(2), S. 85-99.
Roe, E. y Becker, J (2005), «Drug prevention with vulnerable young people: a review», Drugs: education, prevention and policy, 12(2), pp. 85-99.
Roe, E. and Becker, J (2005), ‘Drug prevention with vulnerable young people: a review’, Drugs: education, prevention and policy, 12(2), pagg. 85–99.
Roe, E. και Becker, J (2005), ‘Drug prevention with vulnerable young people: a review’, Drugs: education, prevention and policy, 12(2), σσ. 85–99.
Roe, E. en Becker, J (2005), ‘Drug prevention with vulnerable young people: a review’, Drugs: education, prevention and policy, 12(2), blz. 85-99.
Roe, E. and Becker, J (2005), „Drug prevention with vulnerable young people: a review“, Drugs: education, prevention and policy, 12(2), str. 85–99.
Roe, E. og Becker, J (2005): "Drug prevention with vulnerable young people: a review", Drugs: education, prevention and policy, 12(2), s. 85–99.
Roe, E. ja Becker, J (2005), ”Drug prevention with vulnerable young people: a review”, Drugs: education, prevention and policy, vol. 12 (2), s. 85–99.
Roe, E. és Becker, J (2005), „Drug prevention with vulnerable young people: a review”, Drugs: education, prevention and policy, 12(2), 85–99. o.
Roe, E. og Becker, J (2005), ‘Drug prevention with vulnerable young people: a review’, Drugs: education, prevention and policy, 12(2), s. 85-99.
Roe, E. a Becker, J (2005), ‘Drug prevention with vulnerable young people: a review’, Drugs: education, prevention and policy, 12(2), s. 85 – 99.
Roe, E. in Becker, J (2005), ‘Drug prevention with vulnerable young people: a review’, Drugs: education, prevention and policy, 12(2), str. 85–99.
Roe, E. and Becker, J (2005), ‘Drug prevention with vulnerable young people: a review’, Drugs: education, prevention and policy, 12(2), s. 85–99.
Roe, E. ve Becker, J (2005), ‘Drug prevention with vulnerable young people: a review’, Drugs: education, prevention and policy, 12(2), ss. 85–99.
  Bibliography  
Shearer, J. and Gowing, L.R. (2004), ‘Pharmacotherapies for problematic psychostimulant use: a review of current research’, Drug and alcohol review 23, pp. 203–11.
Shearer, J. et Gowing, L.R. (2004), «Pharmacotherapies for problematic psychostimulant use: a review of current research», Drug and alcohol review 23, pp. 203–11.
Shearer, J. und Gowing, L. R. (2004), „Pharmacotherapies for problematic psychostimulant use: a review of current research“, Drug and alcohol review 23, S. 203-211.
Shearer, J. and Gowing, L.R. (2004), «Pharmacotherapies for problematic psychostimulant use: a review of current research», Drug and alcohol review 23, pp. 203-211.
Shearer, J. and Gowing, L.R. (2004), ‘Pharmacotherapies for problematic psychostimulant use: a review of current research’, Drug and alcohol review 23, pagg. 203–11.
Shearer, J. και Gowing, L.R. (2004), ‘Pharmacotherapies for problematic psychostimulant use: a review of current research’, Drug and alcohol review 23, σσ. 203–11.
Shearer, J. en Gowing, L.R. (2004), ‘Pharmacotherapies for problematic psychostimulant use: a review of current research’, Drug and alcohol review 23, blz. 203-211.
Shearer, J. and Gowing, L.R. (2004), „Pharmacotherapies for problematic psychostimulant use: a review of current research“, Drug and alcohol review 23, str. 203–211.
Shearer, J. og Gowing, L.R. (2004): "Pharmacotherapies for problematic psychostimulant use: a review of current research", Drug and alcohol review 23, s. 203–211.
Shearer, J. ja Gowing, L.R. (2004), ”Pharmacotherapies for problematic psychostimulant use: a review of current research”, Drug and alcohol review vol. 23, s. 203–211.
Shearer, J. és Gowing, L.R. (2004), „Pharmacotherapies for problematic psychostimulant use: a review of current research”, Drug and alcohol review 23, 203–11. o.
Shearer, J. og Gowing, L.R. (2004), ‘Pharmacotherapies for problematic psychostimulant use: a review of current research’, Drug and alcohol review 23, s. 203-11.
Shearer, J. a Gowing, L.R. (2004), ‘Pharmacotherapies for problematic psychostimulant use: a review of current research’, Drug and alcohol review 23, s. 203 – 11.
Shearer, J. in Gowing, L.R. (2004), ‘Pharmacotherapies for problematic psychostimulant use: a review of current research’, Drug and alcohol review 23, str. 203–11.
Shearer, J. and Gowing, L.R. (2004), ‘Pharmacotherapies for problematic psychostimulant use: a review of current research’, Drug and alcohol review 23, s. 203–11.
Shearer, J. ve Gowing, L.R. (2004), ‘Pharmacotherapies for problematic psychostimulant use: a review of current research’, Drug and alcohol review 23, ss. 203–11.
  Bibliography  
Farrell, M., Gowing, L., Marsden, J. et al. (2005), 'Effectiveness of drug dependence treatment in HIV prevention', International journal of drug policy 16S, pp. S67–75.
Farrell, M., Gowing, L., Marsden, J. et al. (2005), «Effectiveness of drug dependence treatment in HIV prevention», International journal of drug policy 16S, pp. S67–75.
Farrell, M., Gowing, L., Marsden, J. et al. (2005), „Effectiveness of drug dependence treatment in HIV prevention“, International journal of drug policy 16S, S. S67-S75.
Farrell, M., Gowing, L., Marsden, J. et al. (2005), «Effectiveness of drug dependence treatment in HIV prevention», International journal of drug policy 16S, pp. S67-75.
Farrell, M., Gowing, L., Marsden, J. e altri (2005), 'Effectiveness of drug dependence treatment in HIV prevention', International journal of drug policy 16S, pagg. S67–75.
Farrell, M., Gowing, L., Marsden, J. κ.ά. (2005), 'Effectiveness of drug dependence treatment in HIV prevention', International journal of drug policy 16S, σσ. S67–75.
Farrell, M., Gowing, L., Marsden, J. et al. (2005), ‘Effectiveness of drug dependence treatment in HIV prevention’, International journal of drug policy 16S, blz. S67-75.
Farrell, M., Gowing, L., Marsden, J. a kol. (2005), „Effectiveness of drug dependence treatment in HIV prevention“, International journal of drug policy 16S, str. S67–75.
Farrell, M., Gowing, L., Marsden, J. m.fl. (2005): "Effectiveness of drug dependence treatment in HIV prevention", International journal of drug policy 16S, s. S67–75.
Farrell, M., Gowing, L., Marsden, J. et al. (2005), ”Effectiveness of drug dependence treatment in HIV prevention”, International journal of drug policy vol. 16S, s. 67–75.
Farrell, M., Gowing, L., Marsden, J. és mások (2005), „Effectiveness of drug dependence treatment in HIV prevention”, International journal of drug policy 16S, S67–75. o.
Farrell, M., Gowing, L., Marsden, J. et al. (2005), 'Effectiveness of drug dependence treatment in HIV prevention', International journal of drug policy 16S, s. S67-75.
Farrell, M., Gowing, L., Marsden, J. a kol. (2005), 'Effectiveness of drug dependence treatment in HIV prevention', International journal of drug policy 16S, s. S67 – 75.
Farrell, M., Gowing, L., Marsden, J. et al. (2005), 'Effectiveness of drug dependence treatment in HIV prevention', International journal of drug policy 16S, str. S67–75.
Farrell, M., Gowing, L., Marsden, J. et al. (2005), 'Effectiveness of drug dependence treatment in HIV prevention', International journal of drug policy 16S, s. S67–75.
Farrell, M., Gowing, L., Marsden, J. vd. (2005), 'Effectiveness of drug dependence treatment in HIV prevention', International journal of drug policy 16S, ss. S67–75.
  Bibliography  
Higgins, S.T., Sigmon, S.C., Wong, C.J. et al. (2003), ‘Community reinforcement therapy for cocaine-dependent outpatients’, Archives of general psychiatry 60, pp. 1043–52.
Higgins, S.T., Sigmon, S.C., Wong, C.J. et al. (2003), «Community reinforcement therapy for cocaine-dependent outpatients», Archives of general psychiatry 60, pp. 1043–52.
Higgins, S. T., Sigmon, S. C., Wong, C. J. et al. (2003), „Community reinforcement therapy for cocaine-dependent outpatients“, Archives of general psychiatry 60, S. 1043-1052.
Higgins, S.T., Sigmon, S.C., Wong, C.J. et al. (2003), «Community reinforcement therapy for cocaine-dependent outpatients», Archives of general psychiatry 60, pp. 1043-1052.
Higgins, S.T., Sigmon, S.C., Wong, C.J. e altri (2003), ‘Community reinforcement therapy for cocaine-dependent outpatients’, Archives of general psychiatry 60, pagg. 1043–52.
Higgins, S.T., Sigmon, S.C., Wong, C.J. κ.ά. (2003), ‘Community reinforcement therapy for cocaine-dependent outpatients’, Archives of general psychiatry 60, σσ. 1043–52.
Higgins, S.T., Sigmon, S.C., Wong, C.J. et al. (2003), ‘Community reinforcement therapy for cocaine-dependent outpatients’, Archives of general psychiatry 60, blz. 1043-1052.
Higgins, S.T., Sigmon, S.C., Wong, C.J. a kol. (2003), „Community reinforcement therapy for cocaine-dependent outpatients“, Archives of general psychiatry 60, str. 1043–1052.
Higgins, S.T., Sigmon, S.C., Wong, C.J. m.fl. (2003): "Community reinforcement therapy for cocaine-dependent outpatients", Archives of general psychiatry 60, s. 1043–1052.
Higgins, S.T., Sigmon, S.C., Wong, C.J. et al. (2003), ”Community reinforcement therapy for cocaine-dependent outpatients”, Archives of general psychiatry vol. 60, s. 1043–1052.
Higgins, S.T., Sigmon, S.C., Wong, C.J. és mások (2003), „Community reinforcement therapy for cocaine-dependent outpatients”, Archives of general psychiatry 60, 1043–52. o.
Higgins, S.T., Sigmon, S.C., Wong, C.J. et al. (2003), ‘Community reinforcement therapy for cocaine-dependent outpatients’, Archives of general psychiatry 60, s. 1043–52.
Higgins, S.T., Sigmon, S.C., Wong, C.J. a kol. (2003), ‘Community reinforcement therapy for cocaine-dependent outpatients’, Archives of general psychiatry 60, s. 1043 – 52.
Higgins, S.T., Sigmon, S.C., Wong, C.J. et al. (2003), ‘Community reinforcement therapy for cocaine-dependent outpatients’, Archives of general psychiatry 60, str. 1043–52.
Higgins, S.T., Sigmon, S.C., Wong, C.J. et al. (2003), ‘Community reinforcement therapy for cocaine-dependent outpatients’, Archives of general psychiatry 60, s. 1043–52.
Higgins, S.T., Sigmon, S.C., Wong, C.J. vd. (2003), ‘Community reinforcement therapy for cocaine-dependent outpatients’, Archives of general psychiatry 60, ss. 1043–52.
  Bibliography  
Prinzleve, M., Haasen, C., Zurhold, H. et al. (2004), 'Cocaine use in Europe – a multi-centre study: patterns of use in different groups', European addiction research 10, pp.147–55.
Prinzleve, M., Haasen, C., Zurhold, H. et al. (2004), «Cocaine use in Europe – a multi-centre study: patterns of use in different groups», European addiction research 10, pp.147–55.
Poling, J., Oliveto, A., Petry, N. et al. (2006), „Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population“, Archives of general psychiatry 63, S. 219-228.
Prinzleve, M., Haasen, C., Zurhold, H. et al. (2004), «Cocaine use in Europe – a multi-centre study: patterns of use in different groups», European addiction research n.º 10, pp.147-155.
Prinzleve, M., Haasen, C., Zurhold, H. e altri (2004), 'Cocaine use in Europe – a multi-centre study: patterns of use in different groups', European addiction research 10, pagg.147–55.
Prinzleve, M., Haasen, C., Zurhold, H. κ.ά. (2004), 'Cocaine use in Europe – a multi-centre study: patterns of use in different groups', European addiction research 10, σσ.147–55.
Prinzleve, M., Haasen, C., Zurhold, H. et al. (2004), ‘Cocaine use in Europe – a multi-centre study: patterns of use in different groups’, European addiction research 10, blz.147-155.
Prinzleve, M., Haasen, C., Zurhold, H. a kol. (2004), „Cocaine use in Europe – a multi-centre study: patterns of use in different groups“, European addiction research 10, str.147–155.
Poling, J., Oliveto, A., Petry, N. m.fl. (2006): "Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population", Archives of general psychiatry 63, s. 219–28.
Prinzleve, M., Haasen, C., Zurhold, H. et al. (2004), ”Cocaine use in Europe – a multi-centre study: patterns of use in different groups”, European addiction research vol. 10, s.147–155.
Prinzleve, M., Haasen, C., Zurhold, H. és mások (2004), „Cocaine use in Europe – a multi-centre study: patterns of use in different groups”, European addiction research 10, 147–55. o.
Prinzleve, M., Haasen, C., Zurhold, H. et al. (2004), 'Cocaine use in Europe – a multi-centre study: patterns of use in different groups', European addiction research 10, s.147-55.
Prinzleve, M., Haasen, C., Zurhold, H. a kol. (2004), 'Cocaine use in Europe – a multi-centre study: patterns of use in different groups', European addiction research 10, s.147–55.
Prinzleve, M., Haasen, C., Zurhold, H. et al. (2004), 'Cocaine use in Europe – a multi-centre study: patterns of use in different groups', European addiction research 10, str.147–55.
Prinzleve, M., Haasen, C., Zurhold, H. et al. (2004), 'Cocaine use in Europe – a multi-centre study: patterns of use in different groups', European addiction research 10, s.147–55.
Prinzleve, M., Haasen, C., Zurhold, H. vd. (2004), 'Cocaine use in Europe – a multi-centre study: patterns of use in different groups', European addiction research 10, ss.147–55.
  Chapter 1: Policies and...  
(6) Council Directive 91/308/EEC of 10 June 1991 on prevention of the use of the financial system for the purpose of money laundering. OJ L 166, 28.06.1991, pp. 77–83.
(6) Directive 91/308/CEE du Conseil du 10 juin 1991 relative à la prévention de l’utilisation du système financier aux fins du blanchiment de capitaux, JO L 166, 28.06.1991, pp. 77 à 83.
(6) Richtlinie 91/308/EWG des Rates vom 10. Juni 1991 zur Verhinderung der Nutzung des Finanzsystems zum  Zwecke der Geldwäsche, ABl. L 166 vom 28.6.1991, S. 77.
(6) Directiva 91/308/CEE del Consejo, de 10 de junio de 1991, relativa a la prevención de la utilización del sistema financiero para el blanqueo de capitales. DO L 166 de 28.6.1991, p. 77.
(6) Direttiva 91/308/CEE del Consiglio, del 10 giugno 1991, relativa alla prevenzione dell’uso del sistema finanziario a scopo di riciclaggio dei proventi di attività illecite. GU L 166, del 28 giugno 1991, pagg. 77–83.
(6) Directiva 91/308/CEE do Conselho, de 10 de Junho de 1991, relativa à prevenção da utilização do sistema financeiro para efeitos de branqueamento de capitais. JO L 166, 28.06.1991, pp. 77–83.
(6) Οδηγία 91/308/ΕΟΚ του Συμβουλίου της 10ης Ιουνίου 1991 για την πρόληψη της χρησιμοποίησης του χρηματοπιστωτικού συστήματος για τη νομιμοποίηση εσόδων από παράνομες δραστηριότητες, ΕΕ L 166, 28.06.1991, σσ. 77–83.
(6) Richtlijn 91/308/EEG van de Raad van 10 juni 1991 tot voorkoming van het gebruik van het financiële stelsel voor het witwassen van geld, PB L 166 van 28.06.1991, blz. 77-83.
(6) Směrnice Rady č. 91/308/EHS ze dne 10. června 1991 o předcházení zneužití finančního systému k praní peněz. Úř. věst. L 166, 28.06.1991, s. 77–83.
(6) Rådets direktiv 91/308/EØF af 10. juni 1991 om forebyggende foranstaltninger mod anvendelse af det finansielle system til hvidvaskning af penge. EFT L 166 af 28.6.1991, s. 77–83.
(6) ukogu 10. juuni 1991. aasta direktiiv 91/308/EMÜ rahandussüsteemi rahapesu eesmärgil kasutamise vältimise kohta. EÜT L 166, 28.06.1991, lk 77–83.
(6) Rahoitusjärjestelmän rahanpesutarkoituksiin käyttämisen estämisestä 10 päivänä kesäkuuta 1991 annettu neuvoston direktiivi 91/308/ETY, EYVL L 166, 28.6.1991, s. 77–83.
(6) Tanács 1991. június 10-i 91/308/EGK irányelve a pénzügyi rendszerek pénzmosás céljára való felhasználásának megelőzéséről, HL L 166., 1991.6.28., 77–83. o.
(6) Rådsdirektiv 91/308/EØF av 10. juni 1991 om tiltak for å hindre at det finansielle system brukes. EUT L 166 av 28.6.1991, s. 77-83.
(6) Dyrektywa Rady 91/308/EWG z 10 czerwca 1991 r. w sprawie uniemożliwienia korzystania z systemu finansowego w celu prania pieniędzy. Dz.U. L 166 z 28.6.1991, str. 77–83.
(6) Directiva 91/308/CEE a Consiliului din 10 iunie 1991 privind prevenirea folosirii sistemului financiar în scopul spălării banilor. JO L 166, 28.06.1991, pp. 77–83.
(6) Smernica Rady 91/308/EHS z 10. júna 1991 o zabránení využívania finančného systému na účely prania špinavých peňazí. Ú. v.  ES L 166, 28.06.1991, s. 77–83.
(6) Direktiva Sveta 91/308/EGS z dne 10. junija 1991 o preprečevanju uporabe finančnega sistema za pranje denarja. UL L 166, 28.6.1991, str. 77–83.
(6) Rådets direktiv 91/308/EEG av den 10 juni 1991 om åtgärder för att förhindra att det finansiella systemet används för tvättning av pengar, EGT L 166, 28.6.1991, s. 77–83.
(6) Finansal sistemin kara para aklama amacıyla kullanımının önlenmesi hakkında 10 Haziran 1991 tarih ve 91/308/AET sayılı Konsey Direktifi. RG L 166, 28.06.1991, s. 77–83.
(6) Padomes 1991. gada 10. jūnija Direktīva 91/308/EEK par to, kā novērst finanšu sistēmas izmantošanu nelikumīgi iegūtas naudas legalizēšanai. OV L 166, 28.06.1991., 77.–83. lpp.
  Bibliography  
Haasen, C., Prinzleve, M., Gossop, M. et al. (2005), 'Relationship between cocaine use and mental health problems in a sample of European cocaine powder and crack users', World psychiatry 4(3), pp. 173–6.
Haasen, C., Prinzleve, M., Gossop, M. et al. (2005), «Relationship between cocaine use and mental health problems in a sample of European cocaine powder and crack users», World psychiatry, 4(3), pp. 173-176.
Haasen, C., Prinzleve, M., Gossop, M. et al. (2005), „Relationship between cocaine use and mental health problems in a sample of European cocaine powder or crack users“, World psychiatry, 4(3), S. 173-176.
Haasen, C., Prinzleve, M., Gossop, M. et al. (2005), «Relationship between cocaine use and mental health problems in a sample of European cocaine powder or crack users», World psychiatry, 4(3), pp. 173-6
Haasen, C., Prinzleve, M., Gossop, M. e altri (2005), 'Relationship between cocaine use and mental health problems in a sample of European cocaine powder and crack users', World psychiatry, 4(3), pagg. 173-176.
Haasen, C., Prinzleve, M., Gossop, M. κ.ά. (2005), 'Relationship between cocaine use and mental health problems in a sample of European cocaine powder and crack users', World psychiatry, 4(3), σσ. 173-6.
Haasen, C., Prinzleve, M., Gossop, M. et al. (2005), ‘Relationship between cocaine use and mental health problems in a sample of European cocaine powder or crack users’, World psychiatry, “4(3), blz. 173-6”.
Haasen, C., Prinzleve, M., Gossop, M. a kol. (2005), „Relationship between cocaine use and mental health problems in a sample of European cocaine powder and crack users“, World psychiatry, 4 (3), str. 173–176.
Haasen, C., Prinzleve, M., Gossop, M. m.fl. (2005): "Relationship between cocaine use and mental health problems in a sample of European cocaine powder and crack users", World psychiatry, oktober.
Haasen, C., Prinzleve, M., Gossop, M. et al. (2005), ”Relationship between cocaine use and mental health problems in a sample of European cocaine powder or crack users”, World psychiatry, 4(3), ss. 173-176.
Haasen, C., Prinzleve, M., Gossop, M. és mások (2005), „Relationship between cocaine use and mental health problems in a sample of European cocaine powder and crack users”, World psychiatry, 4(3), 173-6.o.
Haasen, C., Prinzleve, M., Gossop, M. et al. (2005), 'Relationship between cocaine use and mental health problems in a sample of European cocaine powder and crack users', World psychiatry, Oktober.
Haasen, C., Prinzleve, M., Gossop, M. a kol. (2005), 'Relationship between cocaine use and mental health problems in a sample of European cocaine powder and crack users', World psychiatry, 4(3), s. 173-176.
Haasen, C., Prinzleve, M., Gossop, M. et al. (2005), 'Relationship between cocaine use and mental health problems in a sample of European cocaine powder or crack users', World psychiatry, 4(3), str. 173-6.
Haasen, C., Prinzleve, M., Gossop, M. et al. (2005), 'Relationship between cocaine use and mental health problems in a sample of European cocaine powder and crack users', World psychiatry, 4(3), s. 173-6.
Haasen, C., Prinzleve, M., Gossop, M. vd. (2005), 'Relationship between cocaine use and mental health problems in a sample of European cocaine powder or crack users', World psychiatry, 4(3), ss. 173-6.
  Bibliography  
Poling, J., Oliveto, A., Petry, N. et al. (2006), ‘Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population’, Archives of general psychiatry 63, pp. 219–28.
Poling, J., Oliveto, A., Petry, N. et al. (2006), «Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population», Archives of general psychiatry 63, pp. 219–28.
Poling, J., Oliveto, A., Petry, N. et al. (2006), «Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population», Archives of general psychiatry 63, pp. 219-228.
Poling, J., Oliveto, A., Petry, N. e altri (2006), ‘Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population’, Archives of general psychiatry 63, pagg. 219–228.
Poling, J., Oliveto, A., Petry, N. κ.ά. (2006), ‘Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population’, Archives of general psychiatry 63, σσ. 219–28.
Poling, J., Oliveto, A., Petry, N. et al. (2006), ‘Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population’, Archives of general psychiatry 63, blz. 219-228.
Poling, J., Oliveto, A., Petry, N. a kol. (2006), „Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population“, Archives of general psychiatry 63“, str. 219–228.
Poling, J., Oliveto, A., Petry, N. et al. (2006), ”Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population”, Archives of general psychiatry vol. 63, s. 219–228.
Poling, J., Oliveto, A., Petry, N. és mások (2006), „Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population”, Archives of general psychiatry 63, 219–28. o.
Poling, J., Oliveto, A., Petry, N. et al. (2006), ‘Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population’, Archives of general psychiatry 63, s. 219–28.
Poling, J., Oliveto, A., Petry, N. a kol. (2006), ‘Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population’, Archives of general psychiatry 63, s. 219 – 28.
Poling, J., Oliveto, A., Petry, N. et al. (2006), ‘Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population’, Archives of general psychiatry 63, str. 219–28.
Poling, J., Oliveto, A., Petry, N. et al. (2006), ‘Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population’, Archives of general psychiatry 63, s. 219–28.
Poling, J., Oliveto, A., Petry, N. vd. (2006), ‘Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population’, Archives of general psychiatry 63, ss. 219–28.
  Bibliography  
, O’Brien, M.S. and Anthony, J.C. (2005), ‘Who becomes cannabis dependent soon after onset of use? Epidemiological evidence from the United States: 2000–2001’, Drug and alcohol dependence 79, pp. 11–22.
Chen, C.-Y., O’Brien, M.S. et Anthony, J.C. (2005), «Who becomes cannabis dependent soon after onset of use? Epidemiological evidence from the United States: 2000–2001», Drug and alcohol dependence 79, pp. 11–22.
Chen, C.-Y., O’Brien, M. S. und Anthony, J. C. (2005), „Who becomes cannabis dependent soon after onset of use? Epidemiological evidence from the United States: 2000–2001“, Drug and alcohol dependence 79, S. 11-22.
Chen, C.-Y., O’Brien, M.S. y Anthony, J.C. (2005), «Who becomes cannabis dependent soon after onset of use? Epidemiological evidence from the United States: 2000-2001», Drug and alcohol dependence 79, pp. 11-22.
Chen, C.-Y., O’Brien, M.S. and Anthony, J.C. (2005), ‘Who becomes cannabis dependent soon after onset of use? Epidemiological evidence from the United States: 2000–2001’, Drug and alcohol dependence 79, pagg. 11–22.
Chen, C.-Y., O’Brien, M.S. και Anthony, J.C. (2005), ‘Who becomes cannabis dependent soon after onset of use? Epidemiological evidence from the United States: 2000–2001’, Drug and alcohol dependence 79, σσ. 11–22.
Chen, C.-Y., O’Brien, M.S. en Anthony, J.C. (2005), ‘Who becomes cannabis dependent soon after onset of use? Epidemiological evidence from the United States: 2000-2001’, Drug and alcohol dependence 79, blz. 11-22.
Chen, C.-Y., O’Brien, M.S. a Anthony, J.C. (2005), „Who becomes cannabis dependent soon after onset of use? Epidemiological evidence from the United States: 2000–2001“, Drug and alcohol dependence 79, str. 11–22.
Chen, C.-Y., O’Brien, M.S. og Anthony, J.C. (2005): "Who becomes cannabis dependent soon after onset of use? Epidemiological evidence from the United States: 2000–2001", Drug and alcohol dependence 79, s. 11–22.
Chen, C.-Y., O’Brien, M.S. ja Anthony, J.C. (2005), ”Who becomes cannabis dependent soon after onset of use? Epidemiological evidence from the United States: 2000–2001”, Drug and alcohol dependence vol. 79, s. 11–22.
Chen, C.-Y., O’Brien, M.S. és Anthony, J.C. (2005), „Who becomes cannabis dependent soon after onset of use? Epidemiological evidence from the United States: 2000–2001”, Drug and alcohol dependence 79, 11–22. o.
Chen, C.-Y., O’Brien, M.S. og Anthony, J.C. (2005), ‘Who becomes cannabis dependent soon after onset of use? Epidemiological evidence from the United States: 2000-2001’, Drug and alcohol dependence 79, s. 11–22.
Chen, C.-Y., O’Brien, M.S. and Anthony, J.C. (2005), ‘Who becomes cannabis dependent soon after onset of use? Epidemiological evidence from the United States: 2000–2001’, Drug and alcohol dependence 79, s. 11–22.
Chen, C.-Y., O’Brien, M.S. in Anthony, J.C. (2005), ‘Who becomes cannabis dependent soon after onset of use? Epidemiological evidence from the United States: 2000–2001’, Drug and alcohol dependence 79, str. 11–22.
Chen, C.-Y., O’Brien, M.S. and Anthony, J.C. (2005), ‘Who becomes cannabis dependent soon after onset of use? Epidemiological evidence from the United States: 2000–2001’, Drug and alcohol dependence 79, s. 11–22.
Chen, C.-Y., O’Brien, M.S. ve Anthony, J.C. (2005), ‘Who becomes cannabis dependent soon after onset of use? Epidemiological evidence from the United States: 2000–2001’, Drug and alcohol dependence 79, ss. 11–22.
  Bibliography  
Kandel, D. and Davis, M. (1992), 'Progression to regular marijuana involvement: Phenomenology and risk factors fro near daily use', in: Glantz, M. and Pickens, R. (eds), Vulnerability to Drug Abuse pp. 211–53.
Kandel, D. et Davis, M. (1992), «Progression to regular marijuana involvement: Phenomenology and risk factors for near daily use», in: Glantz, M. and Pickens, R. (eds), Vulnerability to Drug Abuse pp. 211–53. American Psychological Association. Washington.
Kandel, D. und Davis, M. (1992), „Progression to regular marijuana involvement: Phenomenology and risk factors for near daily use“, in: Glantz, M. und Pickens, R. (Hrsg.), Vulnerability to Drug Abuse, S. 211-253. American Psychological Association. Washington.
Kandel, D. y Davis, M. (1992), «Progression to regular marijuana involvement: Phenomenology and risk factors for near daily use», en: Glantz, M. y Pickens, R. (eds.), Vulnerability to Drug Abuse pp. 211-53, American Psychological Association, Washington.
Kandel, D. and Davis, M. (1992), 'Progression to regular marijuana involvement: Phenomenology and risk factors for near daily use', in: Glantz, M. and Pickens, R. (eds), Vulnerability to Drug Abuse pagg. 211–53. American Psychological Association. Washington.
Kandel, D. και Davis, M. (1992), 'Progression to regular marijuana involvement: Phenomenology and risk factors for near daily use', στο: Glantz, M. και Pickens, R. (επιμ.), Vulnerability to Drug Abuse σσ. 211–53. American Psychological Association. Ουάσιγκτον.
Kandel, D. en Davis, M. (1992), ‘Progression to regular marijuana involvement: Phenomenology and risk factors for near daily use’, in: Glantz, M. and Pickens, R. (eds), Vulnerability to Drug Abuse, blz. 211-253. American Psychological Association. Washington.
Kandel, D. a Davis, M. (1992), „Progression to regular marijuana involvement: Phenomenology and risk factors for near daily use“, v publikaci: Glantz, M. a Pickens, R. (eds), Vulnerability to Drug Abuse str. 211–253. Americká psychologická asociace. Washington.
Kandel, D. og Davis, M. (1992): "Progression to regular marijuana involvement: Phenomenology and risk factors fro near daily use", i: Glantz, M. og Pickens, R. (red.): Vulnerability to Drug Abuse, s. 211–253. American Psychological Association. Washington.
Kandel, D. ja Davis, M. (1992), ”Progression to regular marijuana involvement: Phenomenology and risk factors for near daily use”, teoksessa: Glantz, M. ja Pickens, R. (toim.), Vulnerability to Drug Abuse, s. 211–253. American Psychological Association, Washington.
Kandel, D. és Davis, M. (1992), „Progression to regular marijuana involvement: Phenomenology and risk factors for near daily use”, in: Glantz, M. és Pickens, R. (szerk.), Vulnerability to Drug Abuse 211–53. o. American Psychological Association. Washington.
Kandel, D. og Davis, M. (1992), 'Progression to regular marijuana involvement: Phenomenology and risk factors fro near daily use', in: Glantz, M. og Pickens, R. (redaktører), Vulnerability to Drug Abuse s. 211-53. American Psychological Association. Washington.
Kandel, D. a Davis, M. (1992), 'Progression to regular marijuana involvement: Phenomenology and risk factors for near daily use', in: Glantz, M. and Pickens, R. (eds), Vulnerability to Drug Abuse s. 211 – 53. Americká psychologická asociácia. Washington.
Kandel, D. in Davis, M. (1992), 'Progression to regular marijuana involvement: Phenomenology and risk factors for near daily use', v: Glantz, M. in Pickens, R. (eds), Vulnerability to Drug Abuse pp. 211–53. Ameriško psihološko združenje. Washington.
Kandel, D. and Davis, M. (1992), 'Progression to regular marijuana involvement: Phenomenology and risk factors for near daily use', in: Glantz, M. and Pickens, R. (eds), Vulnerability to Drug Abuse s. 211–53. American Psychological Association. Washington.
Kandel, D. ve Davis, M. (1992), 'Progression to regular marijuana involvement: Phenomenology and risk factors for near daily use',: Glantz, M. and Pickens, R. (ed) içinde, Vulnerability to Drug Abuse ss. 211–53. American Psychological Association. Washington.
  Bibliography  
Roozen, H.G., Boulogne, J.J., van Tulder, M.W. et al. (2004), ‘A systematic review of the effectiveness of the community reinforcement approach in alcohol, cocaine and opioid addiction,’ Drug and alcohol dependence 74, pp. 1–13.
Roozen, H.G., Boulogne, J.J., van Tulder, M.W. et al. (2004), «A systematic review of the effectiveness of the community reinforcement approach in alcohol, cocaine and opioid addiction», Drug and alcohol dependence 74, pp. 1–13.
Roozen, H. G., Boulogne, J. J., van Tulder, M. W. et al. (2004), „A systematic review of the effectiveness of the community reinforcement approach in alcohol, cocaine and opioid addiction“, Drug and alcohol dependence 74, S. 1-13.
Roozen, H.G., Boulogne, J.J., van Tulder, M.W. et al. (2004), «A systematic review of the effectiveness of the community reinforcement approach in alcohol, cocaine and opioid addiction», Drug and alcohol dependence 74, pp. 1-13.
Roozen, H.G., Boulogne, J.J., van Tulder, M.W. e altri (2004), ‘A systematic review of the effectiveness of the community reinforcement approach in alcohol, cocaine and opioid addiction,’ Drug and alcohol dependence 74, pagg. 1–13.
Roozen, H.G., Boulogne, J.J., van Tulder, M.W. κ.ά. (2004), ‘A systematic review of the effectiveness of the community reinforcement approach in alcohol, cocaine and opioid addiction,’ Drug and alcohol dependence 74, σσ. 1–13.
Roozen, H.G., Boulogne, J.J., van Tulder, M.W. et al. (2004), ‘A systematic review of the effectiveness of the community reinforcement approach in alcohol, cocaine and opioid addiction,’ Drug and alcohol dependence 74, blz. 1-13.
Roozen, H.G., Boulogne, J.J., van Tulder, M.W. a kol. (2004), „A systematic review of the effectiveness of the community reinforcement approach in alcohol, cocaine and opioid addiction,“ Drug and alcohol dependence 74, str. 1–13.
Roozen, H.G., Boulogne, J.J., van Tulder, M.W. m.fl. (2004): "A systematic review of the effectiveness of the community reinforcement approach in alcohol, cocaine and opioid addiction", Drug and alcohol dependence 74, s. 1–13.
Roozen, H.G., Boulogne, J.J., van Tulder, M.W. et al. (2004), ”A systematic review of the effectiveness of the community reinforcement approach in alcohol, cocaine and opioid addiction”, Drug and alcohol dependence vol. 74, s. 1–13.
Roozen, H.G., Boulogne, J.J., van Tulder, M.W. és mások (2004), „A systematic review of the effectiveness of the community reinforcement approach in alcohol, cocaine and opioid addiction”, Drug and alcohol dependence 74, 1–13. o.
Roozen, H.G., Boulogne, J.J., van Tulder, M.W. et al. (2004), ‘A systematic review of the effectiveness of the community reinforcement approach in alcohol, cocaine and opioid addiction,’ Drug and alcohol dependence 74, s. 1-13.
Roozen, H.G., Boulogne, J.J., van Tulder, M.W. a kol. (2004), ‘A systematic review of the effectiveness of the community reinforcement approach in alcohol, cocaine and opioid addiction,’ Drug and alcohol dependence 74, s. 1 – 13.
Roozen, H.G., Boulogne, J.J., van Tulder, M.W. et al. (2004), ‘A systematic review of the effectiveness of the community reinforcement approach in alcohol, cocaine and opioid addiction,’ Drug and alcohol dependence 74, str. 1–13.
Roozen, H.G., Boulogne, J.J., van Tulder, M.W. et al. (2004), ‘A systematic review of the effectiveness of the community reinforcement asroach in alcohol, cocaine and opioid addiction,’ Drug and alcohol dependence 74, s. 1–13.
Roozen, H.G., Boulogne, J.J., van Tulder, M.W. vd. (2004), ‘A systematic review of the effectiveness of the community reinforcement approach in alcohol, cocaine and opioid addiction,’ Drug and alcohol dependence 74, ss. 1–13.
  Bibliography  
Schottenfeld, R.S., Chawarski, M.C., Pakes, J.R. et al. (2005), ‘Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence’, American journal of psychiatry 162, pp. 340–9.
Schottenfeld, R.S., Chawarski, M.C., Pakes, J.R. et al. (2005), «Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence», American journal of psychiatry 162, pp. 340–9.
Schottenfeld, R. S., Chawarski, M. C., Pakes, J. R. et al. (2005), „Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence“, American journal of psychiatry 162, S. 340-349.
Schottenfeld, R.S., Chawarski, M.C., Pakes, J.R. et al. (2005), «Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence», American journal of psychiatry 162, pp. 340-349.
Schottenfeld, R.S., Chawarski, M.C., Pakes, J.R. e altri (2005), ‘Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence’, American journal of psychiatry 162, pagg. 340–349.
Schottenfeld, R.S., Chawarski, M.C., Pakes, J.R. κ.ά. (2005), ‘Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence’, American journal of psychiatry 162, σσ. 340–9.
Schottenfeld, R.S., Chawarski, M.C., Pakes, J.R. et al. (2005), ‘Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence’, American journal of psychiatry 162, blz. 340-349.
Schottenfeld, R.S., Chawarski, M.C., Pakes, J.R. a kol. (2005), „Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence“, American journal of psychiatry 162“, str. 340–349.
Schottenfeld, R.S., Chawarski, M.C., Pakes, J.R. m.fl. (2005): "Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence", American journal of psychiatry 162, s. 340–9.
Schottenfeld, R.S., Chawarski, M.C., Pakes, J.R. et al. (2005), ”Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence”, American journal of psychiatry vol. 162, s. 340–349.
Schottenfeld, R.S., Chawarski, M.C., Pakes, J.R. és mások (2005), „Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence”, American journal of psychiatry 162, 340–9. o.
Schottenfeld, R.S., Chawarski, M.C., Pakes, J.R. et al. (2005), ‘Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence’, American journal of psychiatry 162, s. 340-9.
Schottenfeld, R.S., Chawarski, M.C., Pakes, J.R. a kol. (2005), ‘Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence’, American journal of psychiatry 162, s. 340 – 9.
Schottenfeld, R.S., Chawarski, M.C., Pakes, J.R. et al. (2005), ‘Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence’, American journal of psychiatry 162, str. 340–9.
Schottenfeld, R.S., Chawarski, M.C., Pakes, J.R. et al. (2005), ‘Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence’, American journal of psychiatry 162, s. 340–9.
Schottenfeld, R.S., Chawarski, M.C., Pakes, J.R. vd. (2005), ‘Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence’, American journal of psychiatry 162, ss. 340–9.
  Bibliography  
Von Sydow, K., Lieb, R., Pfister, H. et al. (2002), ‘What predicts incident use of cannabis and progression to abuse and dependence? A 4-year prospective examination of risk factors in a community sample of adolescents and young adults’, Drug and alcohol dependence 68(1), pp. 49–64.
Von Sydow, K., Lieb, R., Pfister, H. et al. (2002), «What predicts incident use of cannabis and progression to abuse and dependence? A 4-year prospective examination of risk factors in a community sample of adolescents and young adults», Drug and alcohol dependence 68(1), pp. 49–64.
Von Sydow, K., Lieb, R., Pfister, H. et al. (2002), „What predicts incident use of cannabis and progression to abuse and dependence? A 4-year prospective examination of risk factors in a community sample of adolescents and young adults“, Drug and alcohol dependence 68(1), S. 49-64.
Von Sydow, K., Lieb, R., Pfister, H. et al. (2002), «What predicts incident use of cannabis and progression to abuse and dependence? A 4-year prospective examination of risk factors in a community sample of adolescents and young adults», Drug and alcohol dependence 68(1), pp. 49-64.
Von Sydow, K., Lieb, R., Pfister, H. e altri (2002), ‘What predicts incident use of cannabis and progression to abuse and dependence? A 4-year prospective examination of risk factors in a community sample of adolescents and young adults’, Drug and alcohol dependence 68(1), pagg. 49–64.
Von Sydow, K., Lieb, R., Pfister, H. κ.ά. (2002), ‘What predicts incident use of cannabis and progression to abuse and dependence? A 4-year prospective examination of risk factors in a community sample of adolescents and young adults’, Drug and alcohol dependence 68(1), σσ. 49–64.
Von Sydow, K., Lieb, R., Pfister, H. et al. (2002), ‘What predicts incident use of cannabis and progression to abuse and dependence? A 4-year prospective examination of risk factors in a community sample of adolescents and young adults’, Drug and alcohol dependence 68(1), blz. 49-64.
Von Sydow, K., Lieb, R., Pfister, H. a kol. (2002), „What predicts incident use of cannabis and progression to abuse and dependence? A 4-year prospective examination of risk factors in a community sample of adolescents and young adults“, Drug and alcohol dependence 68(1), str. 49–64.
Von Sydow, K., Lieb, R., Pfister, H. m.fl. (2002): "What predicts incident use of cannabis and progression to abuse and dependence? A 4-year prospective examination of risk factors in a community sample of adolescents and young adults", Drug and alcohol dependence 68(1), s. 49–64.
Von Sydow, K., Lieb, R., Pfister, H. et al. (2002), ”What predicts incident use of cannabis and progression to abuse and dependence? A 4-year prospective examination of risk factors in a community sample of adolescents and young adults”, Drug and alcohol dependence vol. 68 (1), s. 49–64.
Von Sydow, K., Lieb, R., Pfister, H. és mások (2002), „What predicts incident use of cannabis and progression to abuse and dependence? A 4-year prospective examination of risk factors in a community sample of adolescents and young adults”, Drug and alcohol dependence 68(1), 49–64. o.
Von Sydow, K., Lieb, R., Pfister, H. et al. (2002), ‘What predicts incident use of cannabis and progression to abuse and dependence? A 4-year prospective examination of risk factors in a community sample of adolescents and young adults’, Drug and alcohol dependence 68(1), s. 49-64.
Von Sydow, K., Lieb, R., Pfister, H. a kol. (2002), ‘What predicts incident use of cannabis and progression to abuse and dependence? A 4-year prospective examination of risk factors in a community sample of adolescents and young adults’, Drug and alcohol dependence 68(1), s. 49 – 64.
Von Sydow, K., Lieb, R., Pfister, H. et al. (2002), ‘What predicts incident use of cannabis and progression to abuse and dependence? A 4-year prospective examination of risk factors in a community sample of adolescents and young adults’, Drug and alcohol dependence 68(1), str. 49–64.
Von Sydow, K., Lieb, R., Pfister, H. et al. (2002), ‘What predicts incident use of cannabis and progression to abuse and dependence? A 4-year prospective examination of risk factors in a community sample of adolescents and young adults’, Drug and alcohol dependence 68(1), s. 49–64.
Von Sydow, K., Lieb, R., Pfister, H. vd. (2002), ‘What predicts incident use of cannabis and progression to abuse and dependence? A 4-year prospective examination of risk factors in a community sample of adolescents and young adults’, Drug and alcohol dependence 68(1), ss. 49–64.